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Excess risk of chronic physical conditions
associated with depression and anxiety
Rituparna Bhattacharya1,2*, Chan Shen3 and Usha Sambamoorthi1,2
Abstract
Background: Depression and anxiety have been reported to be associated with chronic physical conditions. We
examined the excess risk of chronic physical conditions associated with depression and/or anxiety within a
multivariate framework controlling for demographic and modifiable lifestyle risk factors.
Methods: We used a retrospective cross-sectional study design. Study participants were adults aged 22–64 years
from 2007 and 2009 Medical Expenditure Panel Survey. We defined presence of depression-anxiety based on
self-reported depression and anxiety and classified adults into 4 groups: 1) depression only; 2) anxiety only; 3)
comorbid depression and anxiety 4) no depression and no anxiety. We included presence/absence of arthritis,
asthma, chronic obstructive pulmonary disorder, diabetes, heart disease, hypertension, and osteoporosis as
dependent variables. Complementary log-log regressions were used to examine the excess risk associated with
depression and/or anxiety for chronic physical conditions using a multivariate framework that controlled for demographic
(gender, age, race/ethnicity) and modifiable lifestyle (obesity, lack of physical activity, smoking) risk factors. Bonferroni
correction for multiple comparisons was applied and p ≤0.007 was considered statistically significant.
Results: Overall, 7% had only depression, 5.2% had only anxiety and 2.5% had comorbid depression and anxiety. Results
from multivariable regressions indicated that compared to individuals with no depression and no anxiety, individuals with
comorbid depression and anxiety, with depression only and with anxiety only, all had higher risk of all the chronic
physical conditions. ARRs for comorbid depression and anxiety ranged from 2.47 (95% CI: 1.47, 4.15; P = 0.0007) for
osteoporosis to 1.64 (95% CI: 1.33, 2.04; P < 0.0001) for diabetes. Presence of depression only was also found to be
significantly associated with all chronic conditions except for osteoporosis. Individuals with anxiety only were found to
have a higher risk for arthritis, COPD, heart disease and hypertension.
Conclusion: Presence of depression and/or anxiety conferred an independent risk for having chronic physical conditions
after adjusting for demographic and modifiable lifestyle risk factors.
Keywords: Depression, Anxiety, Obesity, Smoking, Physical activity, Chronic physical conditions
Background
Depression and anxiety have been reported to be associated
with chronic physical conditions [1]. Evidences from
cross-sectional, longitudinal studies, systematic reviews,
and meta-analyses have concluded that depression is an
independent risk factor for developing chronic physical
conditions [2-9]. Published research has shown that de-
pression can lead to type 2 diabetes (hereafter referred to
as diabetes) [3], cardiovascular diseases (CVD) [4] and
hypertension [5]. In a Canadian study it was found that
among young adults between 20 and 50 years, prior history
of depression was related to new onset diabetes [10].
Results from meta-analyses showed that individuals with
depression had a 64% increased risk of development of
heart disease [11] and 60% increased risk of diabetes [12].
Several studies also have reported depression as a signifi-
cant predictor of osteoporosis and fractures [6-9]. An
association between depression and Chronic Obstructive
Pulmonary Disease (COPD) is established through an indir-
ect pathway via increased nicotine dependence among
those with depression. [13-15].
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However, there has been mixed findings on the associ-
ation between anxiety and risk for some chronic physical
conditions. A prospective association between anxiety
and risk of hypertension has been reported [16]. A
Danish study also revealed an increased likelihood of
hypertension among those with anxiety disorders [17].
The association between anxiety and risk of developing
diabetes has been inconclusive. While some studies
showed an increased risk of diabetes among those with
anxiety as compared to those without anxiety [18], other
studies have not shown any association between anxiety
and diabetes [19]. Studies have reported an indirect as-
sociation between anxiety and osteoporosis; compared
to adults without anxiety, those with anxiety had lower
hip bone mass density [20], which is a risk factor for
osteoporosis [21]. A recently concluded meta-analysis indi-
cated that depression or anxiety results in a 43% increased
incidence or exacerbation risk of COPD, particularly among
non-elderly adults [22].
In addition, depression and anxiety co-occur in more
than 50% of individuals with depression [23-25]. To the
best of our knowledge, only one study using mental
health survey in 17 countries addressed the association
between comorbid depression and anxiety on risk for
chronic physical conditions [26]. This study concluded
that comorbid depression and anxiety was associated
with increased likelihood of 10 different chronic physical
conditions (asthma, arthritis, back/neck problems, chronic
headache, diabetes, heart disease, hypertension, multiple
pains, obesity and ulcer). For example, the age and gender
adjusted odds ratios (AOR) and 95% Confidence Interval
(CI) for comorbid depression and anxiety was 1.6(1.4, 1.9)
for asthma 2.5(2.2, 2.9) for arthritis and 2.8(2.3, 3.4) for
heart disease, compared to those without depression and
without anxiety.
A general limitation of many of the studies described
above has been the lack of comprehensive controls when
analyzing the association between depression, anxiety
and chronic physical conditions. Individuals with depres-
sion and/or anxiety also have higher rates of obesity
[27,28], smoking [29,30] and lower rates of physical ac-
tivity [31] compared to those without depression and
without anxiety. In addition, studies have documented
that modifiable lifestyle risk factors such as obesity, lack
of physical activity, and smoking can contribute to the
increased risk for chronic physical conditions [32-34].
Therefore it is very important to control for these risk
factors in order to assess the excess risk of chronic
physical conditions associated with the presence of
depression and anxiety.
The primary purpose of our study was to examine ex-
cess risk of a diverse set of chronic physical conditions
associated with depression and/or anxiety in a non-
elderly adult population within a multivariate framework
that controlled for demographic and modifiable lifestyle
risk factors. We focus on the non-elderly adult popula-
tion because individuals with depression and/or anxiety
may develop chronic physical conditions at an earlier age
as compared to general population [2]. We hypothesize that
even after controlling for these risk factors individuals with
depression and/or anxiety will have a greater risk of arth-
ritis, asthma, COPD, diabetes, heart disease, hypertension




We used a retrospective cross-sectional study design using
data from a nationally representative household survey in
the United States (US).
Data source and setting
The current study utilized data from the annual releases of
2007 and 2009 Medical Expenditure Panel Survey (MEPS),
a nationally representative annual survey of households
representing the US non-institutionalized civilian popula-
tion. The survey adopted a multistage, clustered sample
design [35].
The household component (HC) is the core of the
MEPS data. Extensive health care utilization data, in-
cluding demographics, health conditions, health status,
use of medical care and prescription medications, de-
tailed charges and payment, insurance coverage, income,
and employment are captured in the HC through annual
computer-assisted in-person (CAPI) interviews. Informa-
tion on medical conditions can be derived from the
Medical Conditions file of the HC of MEPS. Details of
how medical conditions were derived from these files
are provided in the Measures section below.
Analytic sample
We restricted our analytical sample to individuals who
were between the ages of 22 and 64 years, were not
underweight (i.e. BMI <18.5 kg/m2), and were alive as of
the end of the calendar years 2007 and 2009. Based on
these selection criteria, participants from 2007 and 2009
MEPS data were pooled together to yield a final sample
of 33,242 participants. In our study sample, a very small
number (only 1.2%) of adults were in the underweight
BMI group and therefore we excluded underweight
BMI group from our analytic sample. Individuals with
self-reported schizophrenia, psychoses, attention def-
icit hyper activity disorders, adjustment disorders,
substance abuse disorders and personality disorders
were excluded from analysis.
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Measures
Dependent variables: presence/absence of chronic
physical conditions
As mentioned above, chronic physical conditions were
derived from medical conditions file. The MEPS investi-
gators followed many procedures to minimize under-
reporting of medical and mental health conditions.
Conditions can be reported: (1) in the Priority Condition
Enumeration section in which respondents are asked if
they have been diagnosed by a doctor or other health
care professional with specific conditions. The priority
conditions for 2007 and 2009 included (i) long term
life threatening conditions like Cancer, Hypertension/
High Blood Pressure, Diabetes/Sugar Diabetes, High
Cholesterol Ischemic Heart Disease, Stroke, HIV/AIDS
and Emphysema (ii) chronic manageable conditions
like Arthritis, Chronic Bronchitis, Asthma, Joint Pain,
Gall Bladder Diseases, Stomach Ulcers, Back Prob-
lems of any kind and (iii) mental health issues like
Alzheimer’s Disease and Other Dementias, depression
and anxiety, Attention Deficit Hyperactivity Disorder
(ADHD)/Attention Deficit Disorder (ADD) (2) if the
respondents sought care for a reported condition (hos-
pital stay, outpatient visit, emergency room visit, home
health episode, prescribed medication purchase, or
medical provider visit) (3) if the respondents reported
one or more episodes of disability days due to a spe-
cific condition and (4) if the condition was “bothering”
the person during the reference period. Health prob-
lems as defined by MEPS refers to “physical conditions,
accidents, or injuries that affect any part of the body as
well as mental or emotional health conditions, such as
feeling sad, blue, or anxious about something.” These
self-reported conditions are then mapped to Inter-
national Classification of Diseases (ICD-9-CM) diag-
nosis codes and further recoded to aggregate clinical
classification codes (CCCODEX) by MEPS researchers.
The cross-walk file between ICD-9-CM codes and clin-
ical classification codes are published [36]. In order to
minimize bias associated with self-reported data, upon
completion of the household CAPI interview and
obtaining permission from the household survey re-
spondents, a sample of medical providers are contacted
by telephone to obtain information that household re-
spondents could not accurately provide [35,37].
In this paper, chronic physical conditions consisted
of self-reported diagnosis of asthma, COPD, diabetes,
heart disease, hypertension, arthritis and osteoporosis.
Heart disease included heart valve disorders, peri-
endo-, and myocarditis, cardiomyopathy, acute myo-
cardial infarction, coronary atherosclerosis and other
heart disease, non-specific chest pain, pulmonary heart
disease, conduction disorders, cardiac dysrhythmias,
congestive heart failure and other and ill-defined heart
disease. Arthritis included Infective arthritis and osteo-
myelitis (except that caused by tuberculosis or sexually
transmitted disease), rheumatoid arthritis and related
disease, osteoarthritis and other non-traumatic joint
disorders. These chronic physical conditions were
selected based on prevalence, economic, morbidity and
mortality burden [38]. We used three-digit International
Classification of Diseases-9th edition-Clinical Modification
(ICD-9-CM) and clinical classification codes provided in
the medical care event files to identify presence of these
conditions.
Key independent variable: depression-anxiety status
Presence of depression and/or anxiety was derived from
the Medical Conditions file. We used clinical classifica-
tion codes to identify depression (code: 657) and anxiety
(code: 651). Based on the presence of depression and
anxiety we categorized the individuals into 4 groups: 1)
Depression only (individuals with only depression and
no anxiety); 2) Anxiety Only (individuals with only anx-
iety and no depression); 3) Comorbid depression and
anxiety (individuals with both depression and anxiety);
and 4) No depression and no anxiety (individuals with
neither depression nor anxiety).
Other independent variables
We also included variables that may be associated with
risk for chronic physical conditions. These included
demographic factors (gender, age, race/ethnicity, and
metro status), socio-economic status (education and
poverty status), access to care (health insurance), and
modifiable life-style risk factors. Modifiable life-style risk
factors were overweight and obesity as measured by
Body Mass Index (BMI) values, lack of physical activity,
current smoking status. BMI was grouped into three cat-
egories: normal BMI (18.5 kg/m2-24.9 kg/m2); over-
weight (25 kg/m2-29.9 kg/m2); and obese (≥ 30 kg/m2 )
[39]. Lack of physical activity was measured as a binary
variable based on vigorous activity at least three days a
week (Yes/No). Current smoking status was grouped as
current smoker, former smoker, and never smoked.
Statistical techniques
Significant bivariate group differences in the association
between depression-anxiety status and chronic physical
conditions were tested with chi-square statistic. Logistic
regressions are commonly used to estimate the associ-
ation between binary dependent variable and other inde-
pendent variables. However, the AORs from logistic
regressions cannot be interpreted as risk when the dis-
ease prevalence is high (i.e. >10%), as is the case for
many of our chronic conditions, since AORs fail to give
approximations for risk [40]. Simulation studies have
shown that complementary log-log (CLL) regression
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models can be used as an alternative statistical model
for estimating multivariable-adjusted prevalence ratios
and their confidence intervals [41]. The CLL regression
models can be easily implemented with standard statis-
tical software packages such as Statistical Analysis Soft-
ware (SAS). In the current study, coefficients from CLL
regressions were exponentiated to summarize the excess
risk of chronic physical conditions associated with
depression-anxiety status [42]. The CLL regressions in-
cluded all the independent variables mentioned in the
“Measures” section. For our key independent variable,
depression-anxiety status, “no depression and no anx-
iety” group was used as the reference category. All ana-
lyses accounted for the complex design of MEPS. As we
tested our hypothesis for seven different chronic physical
conditions, the significance level for multiple compari-
sons was controlled by applying the Bonferroni correc-
tion for multiple comparisons and p ≤ 0.007 was
considered statistically significant. Analyses were per-
formed in SAS 9.3 [43].
Results
In our study sample of young adults between the ages of
22 and 64 years (data not presented in tabular form),
majority of the study sample were white (66%), women
(51%), lived in a metro area (85%), and had private insur-
ance (73%). Forty-eight percent had college education
and 43% had incomes representing 400% or more federal
poverty line. Nearly 1 in five individuals were current
smokers and 60% exercised more than 3 time each week;
overall, 31% reported a normal BMI; 35% were classified
as overweight; and 30% were categorized as obese based
on BMI values.
Table 1 presents the distribution of study sample char-
acteristics by depression-anxiety anxiety status. Overall,
7% had depression only, 5% had anxiety only and 3%
had comorbid depression and anxiety. We observed sig-
nificant group differences in depression-anxiety status by
all the variables included in the study. A higher propor-
tion of women (3.7%) than men (1.6%) reported comor-
bid depression and anxiety compared to no depression
and no anxiety. A higher proportion of individuals with
comorbid depression and anxiety were poor compared
to those who had high income (4.8% vs. 1.9%), were
obese as compared to those with normal weight (3.6%
vs. 2.4%), were current smokers compared to individuals
who never smoked or were former smokers (4.5% vs.
2.3%). Similar findings were noted for depression only
and anxiety only categories.
Rates of chronic physical conditions by depression-
anxiety status are presented in Table 2. The percentage
of individuals with chronic physical conditions was high-
est in the group with comorbid depression and anxiety,
followed by those with only depression only, anxiety
only and those with no depression and no anxiety. Indi-
viduals with comorbid depression and anxiety had the
highest prevalence of arthritis (39%) followed by hyper-
tension (35%), COPD (21%), heart disease (17%), dia-
betes (15%), asthma (14%) and osteoporosis (4%).
In Table 3, we present the adjusted risk ratios (ARRs)
and 95% Confidence intervals (CI) from CLL regressions
for depression-anxiety status after controlling for demo-
graphic, socio-economic, access to care and modifiable
life-style risk factors. Results from CLL regressions indi-
cated that compared to individuals with no depression
and no anxiety, groups with comorbid depression and
anxiety had greater risk of all chronic physical condi-
tions. The ARRs for comorbid depression and anxiety
ranged from 2.47 (95% CI: 1.47, 4.15; P = 0.0007) for
osteoporosis to 1.64 (95% CI: 1.33, 2.04; P < 0.0001) for
diabetes. Presence of depression only was also found to
be significantly associated with all chronic conditions ex-
cept for osteoporosis. ARRs ranged 1.94 (95% CI: 1.75,
2.14; P < 0.0001) for arthritis to 1.49 (95% CI: 1.36, 1.64;
P < 0.0001) for heart disease. Individuals with anxiety
only were found to have a higher risk for arthritis (ARR:
1.71, 95% CI: 1.54, 1.90; P < 0.0001), COPD (ARR: 1.62,
95% CI: 1.37, 1.91; P < 0.0001), heart disease (ARR: 1.74,
95% CI: 1.45, 2.09; P < 0.0001) and hypertension (ARR:
1.48, 95% CI: 1.31, 1.68; P < 0.0001).
Secondary analyses
It is plausible that use of psychotropic medications may
be independently associated with higher risk of chronic
physical conditions compared to those without psycho-
tropic medications use. For example, Paroxetine, a se-
lective serotonin reuptake inhibitors often used to treat
depression may hamper the function of vascular endo-
thelial cells by impairing endothelial nitric oxide syn-
thase, thus affecting arterial integrity leading to
cardiovascular diseases [44]. Tricyclic antidepressants
can affect cardiac conduction and rhythm, and could be
cardiotoxic [45] leading to greater risk of developing
heart disease. Elevated risk for glucose dysregulation,
weight gain and new onset diabetes has been observed
with the use of antipsychotic and antidepressants medi-
cations [46-48]. Both typical and atypical antipsychotic
medications are known to induce hyperprolactinemia
[49] which leads to bone loss, a major risk factor for
osteoporosis [50]. We tested this by additionally includ-
ing psychotropic medication use in the complementary
log-log regression models. Psychotropic medication use
was identified from prescription drug files using Multum
Lexicon therapeutic categories (category code = 242).
Overall, 11.4% of the study sample used psychotropic
medications; 80% of those with comorbid depression
and anxiety, 67% of those with depression only, 40% of
those with anxiety only and 2.5% of those with no
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Table 1 Description of study sample by depression-anxiety status medical expenditure panel survey, 2007-2009




N Wt% N Wt% N Wt% N Wt% P-value
ALL 2,326 7.3 1,719 5.6 849 2.7 28,348 84.4
Gender < .0001
Women 1,610 9.5 1,121 7.1 618 3.7 14,452 79.7
Men 716 5.2 598 4.0 231 1.6 13,896 89.2
Race/ethnicity < .0001
White 1,454 8.6 1,065 6.5 568 3.2 12,704 81.8
African American 309 4.7 214 3.5 95 1.7 5,256 90.1
Latino 454 5.3 332 4.1 145 1.6 7,845 89.1
Others 109 4.6 108 3.9 41 1.6 2,543 89.9
Age in years < .0001
21-39 749 5.6 663 5.2 265 2.0 12,414 87.2
40-49 633 7.9 449 5.7 217 2.8 7,199 83.5
50 – 64 944 9.1 607 6.0 367 3.4 8,735 81.5
Metro status 0.0048
Metro 1,919 7.1 1,466 5.6 698 2.6 24,468 84.7
Not Metro 407 8.8 253 5.4 151 3.1 3,880 82.8
Education 0.0063
Less than high school 505 8.1 306 5.0 196 3.1 5,725 83.8
High school 748 8.0 498 5.5 253 2.8 8,629 83.7
College 1,063 6.8 911 5.8 395 2.5 13,724 84.8
Health insurance < .0001
Private 1,347 6.8 1,204 5.9 460 2.3 18,452 85
Public 566 15 255 6.7 287 8.2 2,973 70
Uninsured 413 6.2 260 3.7 102 1.7 6,923 88.4
Poverty status < .0001
Poor 515 10.5 271 5.9 234 4.8 4,222 78.7
Near poor 525 8.4 305 5.1 173 3.2 5,811 83.4
Middle income 625 6.7 561 5.9 243 2.7 8,897 84.6
High income 661 6.6 582 5.4 199 1.9 9,418 86.1
Body mass index categories < .0001
Normal 603 6.0 517 5.7 238 2.4 8,830 85.9
Overweight 688 6.3 559 5.0 243 2.1 10,120 86.5
Obese 980 10.0 602 6.1 351 3.6 8,520 80.2
Smoking status < .0001
Current smoker 650 10.2 415 7.0 284 4.5 5,011 78.3
Former/never smoked 1,529 6.7 1,216 5.4 529 2.3 21,037 85.6
Physical activity < .0001
Vigorous activity at least 3 days/week 1,062 5.8 916 5.2 360 2.0 16,394 86.9
Other 1,255 9.7 796 6.3 486 3.7 11,630 80.3
Note: Study sample comprised of adults aged 22–64 years alive during the calendar year without self-reported diagnosis of schizophrenia, psychoses, attention
deficit hyper activity disorders, adjustment disorders, substance abuse disorders and personality disorders.
Wt: Weighted.
Significant if p < =0.007.
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depression and no anxiety had psychotropic medication
use. Among those with comorbid depression and anxiety,
non-users of psychotropic medication varied by type of
chronic physical conditions; among those with diabetes and
comorbid depression and anxiety, only 0.4% did not use
psychotropic medications; similar findings were noted for
hypertension (0.6%), arthritis (0.9%), COPD (1.1%), heart
disease (1.2%), arthritis (1.5%) and osteoporosis (1.5%),
When we additionally included use of psychotropic medi-
cations along with other independent variables mentioned
in the measures section, we found that psychotropic medi-
cation use was independently associated with increased risk
of arthritis (ARR: 1.28; 95% CI: 1.15-1.42; P < 0.0.0001), dia-
betes (ARR: 1.51; 95% CI: 1.27-1.78; P < 0.0.0001) and
hypertension (ARR: 1.23; 95% CI: 1.13-1.42; P < 0.0.0001).
The association between depression-anxiety status and
higher risk of chronic physical conditions remained
the same except for diabetes. The association between
comorbid depression and anxiety and osteoporosis was
no longer statistically significant after controlling for
psychotropic medication use. However, one needs to use
extreme caution in interpreting these results, because of
the very high correlation between psychotropic medica-
tion use and depression anxiety status variable (> 0.66)
and very small sample size in comorbid depression and
anxiety and no psychotropic medication for some of the
chronic conditions. Results from these regression models
are available from the first author upon request.
Discussion
Our paper examined the excess risk of chronic physical
conditions associated with depression and/or anxiety
among non-elderly adults after controlling for a compre-
hensive list of demographic, socio-economic, access to
care, and modifiable lifestyle risk factors for chronic con-
ditions. In our study sample of non-elderly adults 15.6%
Table 3 Associations between depression-anxiety status and chronic physical conditionsa adjusted risk ratios (ARR)
and 95% confidence intervals medical expenditure panel survey, 2007 and 2009
Depression only Anxiety only Comorbid
Depression and anxiety
ARR [95% CI] P-value ARR [95% CI] P-value ARR [95% CI] P-value
Arthritis 1.94 [1.75,2.14] <0.0001 1.71 [1.54,1.90] <0.0001 2.04 [1.79,2.33] <0.0001
Asthma 1.78 [1.50,2.11] <0.0001 1.4 [1.13,1.75] 0.0023 2.16 [1.66,2.81] <0.0001
COPD 1.76 [1.54,2.02] <0.0001 1.62 [1.37,1.91] <0.0001 2.05 [1.68,2.49] <0.0001
Diabetes 1.59 [1.37,1.84] <0.0001 1.21 [1.00,1.47] 0.0457 1.64 [1.33,2.02] <0.0001
Heart disease 1.56 [1.34,1.81] <0.0001 1.74 [1.45,2.09] <0.0001 2.16 [1.77,2.63] <0.0001
Hypertension 1.49 [1.36,1.64] <0.0001 1.48 [1.31,1.68] <0.0001 1.66 [1.44,1.93] <0.0001
Osteoporosis 1.78 [1.22,2.61] 0.0433 1.6 [1.01,2.53] 0.0029 2.47 [1.47,4.15] 0.0007
Note: Analytic sample comprised of adults, 22–64 years of age with no self-reported diagnosis of schizophrenia, psychoses, attention deficit hyper activity
disorders, adjustment disorders, substance abuse disorders and personality disorders.
Reference group for multivariable complementary log-log regression estimates: “no depression and no anxiety
aModel Controlled for modifiable lifestyle risk factors (weight-status, physical activity, smoking status), age, gender, race/ethnicity, education, whether residing in a
metro area (yes/no) and health insurance.
COPD = Chronic Obstructive Pulmonary Disease.
Significant if P < =0.007.
Table 2 Number and weighted percentage of chronic physical conditions by depression-anxiety status medical
expenditure panel survey, 2007-2009
Depression only Anxiety only Comorbid depression and anxiety No depression and no anxiety
N Wt% N Wt% N Wt% N Wt% P-value
Arthritis 831 34.3 481 27.2 360 38.8 4,114 14.8 < .0001
Asthma 258 10.2 131 7.2 131 13.8 1,195 4.2 < .0001
COPD 403 16.7 235 13.7 196 21.3 1,925 7.1 < .0001
Diabetes 348 13.2 165 8.2 139 14.7 2,063 6.2 < .0001
Heart disease 301 11.2 195 10.5 149 16.9 1,449 5.3 < .0001
Hypertension 786 30.6 470 25.5 313 34.5 5,092 16.9 < .0001
Osteoporosis 50 2.1 32 2.0 26 3.5 199 0.8 < .0001
Note: Study sample comprised of adults, 22–64 years of age, alive during the calendar year and without self-reported diagnosis of schizophrenia, psychoses,
attention deficit hyper activity disorders, adjustment disorders, substance abuse disorders and personality disorders.
COPD: Chronic Obstructive Pulmonary Disease; Wt: Weighted.
Significant if p < =0.007.
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had either depression or anxiety or both. In multivari-
able regressions, we found that depression-anxiety status
was associated with greater risk of asthma, arthritis,
COPD, diabetes, heart disease, hypertension, and osteo-
porosis. While our research focused on the one-way re-
lationship between depression-anxiety status and risk of
chronic conditions, one cannot rule out bidirectional as-
sociations. Bidirectional association between depression
and/or anxiety and risk of many medical illness such as
diabetes [1], hypertension, cardiovascular diseases [1,51],
COPD [22,52], asthma [52], arthritis [53] and osteoporosis
[54] has been documented. However, owing to the cross-
sectional design used in the study, we were unable to test
any bidirectional associations between depression-anxiety
status and the risk of chronic physical conditions.
Although not directly analyzed in this study, we can
speculate on the reasons for excess risk for chronic
physical conditions associated with depression and/or
anxiety. Prior research has attributed this excess risk to
biological factors [44], use of psychotropic medications
[44] as well as access to care issues [55]. Several bio-
logical mechanisms including decreased heart rate vari-
ability [56,57], increased platelet aggregation [58], higher
levels of inflammatory risk markers (C-reactive protein and
interleukin-6) [59] among individuals with depression and/
or anxiety may lead to increased risk for cardiovascular
diseases. Hypothalamic-pituitary-adrenocortical (HPA) axis
dysregulation and sympathetic nervous system stimulation
associated with glucose homeostasis are suggested explana-
tions for the observed association of diabetes with depres-
sive symptoms and major depression [60]. The pathogenic
mechanisms of COPD and depression and/or anxiety are
complex. Common symptomologies such as shortness of
breath or dyspnea, and hyperventilation are observed in in-
dividuals with COPD as well as panic anxiety [61]. Further-
more, both anxiety and depression are associated with
activation of the HPA axis and increased systemic inflam-
matory responses which may be responsible for increased
risk of COPD exacerbations [62-66]. Dysregulation of
certain stress-sensitive biological processes such as the
autonomic nervous system, that contribute to the patho-
physiology of both conditions, may explain the association
between depression and/or anxiety and asthma [67]. The
association between arthritis and depression can be attrib-
uted to the relationship between depression and inflamma-
tion; various inflammation markers such as C-reactive
proteins are positively associated with depression [68].
The association between depression and low bone
mineral density certainly helps to explain the risk of
osteoporosis in this population [9].
Individuals with depression and/or anxiety may face a
wide array of patient-, provider- and system-level bar-
riers, which can restrict access to needed medical care.
Such restricted healthcare access may increase the risk
of chronic physical conditions. It has been reported that
individuals with depression had problems with all four
domains of primary care namely access, comprehensive-
ness, co-ordination and continuity of care [10]. Again in-
dividuals with anxiety often lack planned follow up and
monitoring, which can be a barrier for effective
preventive healthcare to reduce the risk of developing
chronic conditions [69]. As primary care use have been
shown to be effective in modifying the risk factors for
chronic physical conditions [70], lack of appropriate pri-
mary care among individuals with depression and/or
anxiety can also lead to development of chronic physical
conditions. The emerging healthcare delivery models
such as patient-centered medical homes and accountable
care organizations, in which emphasis has been placed
on primary care, [71] may facilitate efforts to reduce the
risk of chronic physical conditions. Future research
needs to evaluate the success of these emerging health-
care delivery models in effectively reducing the risk of
chronic physical conditions in vulnerable individuals
with depression and/or anxiety.
Findings from our study indicated that individuals with
depression and/or anxiety are more likely to suffer from
poor physical health, high rates of obesity and smoking.
These findings highlight the need for integrating wellness
efforts within mental healthcare settings. In addition, em-
phasis on physical wellness needs to be part of broader ef-
forts to improve mental health [72]. In order to improve
both physical and mental health, primary care services need
to be integrated within mental health settings (reverse
integration). Randomized trials and experimental studies
have provided evidence on the beneficial effects of inte-
grated primary care and mental health care for patients
with depression and/or anxiety [73]. In addition to wellness
efforts, routine screening for depression and/or anxiety
along with co-ordinated mental-health care for those who
screen positive for depression and/or anxiety may reduce
the risk of chronic physical conditions.
The study had a number of strengths, including na-
tionally representative sample, comprehensive list of
independent variables that may affect chronic physical
conditions and the ability to analyze the association
between depression-anxiety status and a number of
chronic physical conditions. We were also able to as-
sess the independent effects of depression only, anxiety
only, and comorbid depression and anxiety on risk of
chronic conditions. Limitations have to be considered
when interpreting the findings of the present study.
The study design is retrospective, observational, and cross-
sectional and therefore cannot establish causal relation-
ships. Study variables are based on self-reported data which
might be subject to reporting-bias. As our study assessed
the excess risk of chronic physical conditions among non-
elderly adults, the study results are not generalizable to
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other age groups. Although we adjusted for a large number
of risk factors that may affect presence of chronic condi-
tions, some variables such as family history that could con-
tribute to the excess risk of chronic physical conditions
were not available. Finally, our study was not immune to
the inherent limitations associated with use of secondary
data such as measurement errors, errors in data editing and
imputation, sampling and non-sampling errors, reporting
errors and interviewer effects.
Conclusions
Despite the limitations, our study has made a unique
contribution to the literature by analyzing the independ-
ent contribution of depression, anxiety, and comorbid
depression and anxiety on the risk of having chronic
physical conditions, after controlling for demographic,
life-style, and other important risk factors. Our study
findings confirmed that even after adjusting for modifi-
able lifestyle risk factors, depression and/or anxiety
made an independent contribution to the excess risk for
many chronic physical conditions. Our study findings
highlight the need to minimize the burden of depression
and anxiety either through better surveillance, monitor-
ing and treatment of these conditions, which may in
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